EVOGENE LTD. Cash And Cash Equivalents
EVOGENE LTD. (EVGN) had Cash And Cash Equivalents of $12.96 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-26
- 2025-12-31: Cash And Cash Equivalents $12.96M.
- 2025-06-30: Cash And Cash Equivalents $8.33M.
- 2024-12-31: Cash And Cash Equivalents $15.30M.
- 2024-06-30: Cash And Cash Equivalents $9.48M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $12.96M 20-F · filed 2026-03-26 |
| 2025-06-30 | $8.33M 6-K · filed 2025-09-30 |
| 2024-12-31 | $15.30M 20-F · filed 2026-03-26 |
| 2024-06-30 | $9.48M 6-K · filed 2025-09-30 |
| 2023-12-31 | $20.77M 20-F · filed 2026-03-26 |
| 2023-06-30 | $20.23M 6-K · filed 2024-09-16 |
| 2022-12-31 | $28.98M 20-F · filed 2026-03-26 |
| 2022-06-30 | $28.87M 6-K · filed 2023-09-13 |
| 2021-12-31 | $32.33M 20-F · filed 2025-03-27 |
| 2021-06-30 | $42.76M 6-K · filed 2022-09-07 |
| 2020-12-31 | $46.23M 20-F · filed 2024-03-28 |
| 2020-06-30 | $31.07M 6-K · filed 2021-08-31 |
| 2019-12-31 | $34.75M 20-F · filed 2023-03-30 |
| 2019-06-30 | $14.10M 6-K · filed 2020-09-15 |
| 2018-12-31 | $5.81M 20-F · filed 2022-03-31 |
| 2017-12-31 | $3.44M 20-F · filed 2021-04-02 |
| 2016-12-31 | $3.24M 20-F · filed 2020-04-27 |
| 2015-12-31 | $10.22M 20-F · filed 2019-04-29 |
| 2014-12-31 | $5.21M 20-F · filed 2018-03-30 |